abrdn Healthcare Investors Overview
Pro stress-test →abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. that invests in public equity markets globally, seeking exposure to stocks of healthcare companies including biotechnology, medical devices, and pharmaceuticals. The fund primarily invests in growth stocks of small cap companies.
Strategic Profile
Pro stress-test →The fund employs fundamental analysis focusing on current or anticipated market position, experienced business management, recognized technological expertise, and ability to generate or secure capital for growth. abrdn Healthcare Investors offers a discounted entry into the healthcare sector, with a strong tilt toward biotechnology exposure and active management.
Competitive Landscape
Pro stress-test →HQH is compared against peers including Calamos Convertible & High Income (CHY), ClearBridge Energy Midstream Opportunity (EMO), Nuveen NY AMT - Free Quality Muni Inc (NRK), and abrdn Total Dynamic Dividend (AOD). The fund competes for healthcare-focused income investors seeking small-cap growth exposure with dividend distributions.
Industry Context
abrdn Healthcare Investors operates in Closed-End Funds / Asset Management.
Key facts
Founded: 1986 · Headquarters: Philadelphia, US · Revenue: $7.53M · Market cap: $1.1B